CEVA Animal Health has launched Diarsanyl Plus, a new intestinal support paste for dogs, cats and small animals containing prebiotics.
Diarsanyl Plus contains the same unique combination of ingredients as Diarsanyl - montmorillonite, Na+, Mg2+ and K+ ions and dextrose - but now also contains prebiotics called fructo-oligosaccharides (FOS).
According to the company, montmorillonite maintains intestinal function by coating and protecting the enterocytes and absorbing toxins, Na+, Mg2+ and K+ ions help maintain electrolyte levels and dextrose provides a much needed energy source for the small intestine. The prebiotics help maintain normal intestinal flora by promoting the growth of good bacteria such as bifidobacteria and lactobacilli and stimulating the production of short chain fatty acids (SCFAs) - acetate, propionate and butyrate - which are important energy sources for the large intestine.
Fraser Broadfoot, product manager at CEVA Animal Health said: "Diarsanyl Plus will build on the proven efficacy of Diarsanyl by including prebiotics that naturally balance the intestinal flora of animals with digestive upsets and diarrhoea. The new easy-to-use syringes and palatable formulation will also make it easier for pet owners to administer."
Diarsanyl Plus is available in 10ml, 24ml and 60ml pack sizes for a variety of species, from small animals to large dogs.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Pet owners visiting the University of Edinburgh's vet school will be able to relax in peaceful outdoor surroundings, thanks to a project supported by the BBC's Beechgrove Garden.
The primetime gardening show's team, together with volunteers and friends of the Royal (Dick) School of Veterinary Studies, have transformed a two-and-a-half-acre plot in the vet school grounds into a community garden.
The sloping landscaped garden features a network of paths surrounding flower beds, trees and bushes. Sculpted stone seats give visitors a place to relax. Clients of the Dick Vet are being invited to support the school by sponsoring a brick along a path that winds through the garden, or by sponsoring trees, plants or benches.
Lesley Watson, a Beechgrove Garden presenter, said: "We have had a lot of help from the community in creating this garden, in what was a huge site. The first part of the garden, next to the School buildings, is quite formal, but as it extends towards the hills beyond, it becomes a more relaxed space and starts to take on aspects of the wider landscape."
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies, said: "This wonderful garden is a fantastic place for our pet owners to visit and also a beautiful green retreat for our staff and students to enjoy."
Inez Priestly, a dog owner whose pets have been treated at the Dick Vet, laid the first brick in the garden's path of memories, in honour of her late Cavalier King Spaniel, Treacle. Mrs Priestly said: "The treatment my dogs have received at the Dick Vet has been beyond words - the vets always empathise with their clients and go the extra mile to help. I'm delighted to lay this first brick in the new garden and hope this will encourage others to do the same, as a way of thanking the Dick Vet."
(Photos courtesy Norrie Russell, University of Edinburgh)
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
The company says that as a community interest company, it can help to bridge the gap between charities, which provide help only for those who are eligible, and commercial practices, which are becoming increasingly unaffordable as they are acquired by corporates and private equity companies.
The rules governing CIC companies mean that their assets can only be used for their social objectives and there is a limit to the money that can be distributed to shareholders: 5% above the Bank of England base rate to a maximum of 35% of profits.
Animal Trust does not charge consultation fees, so all pets are initially seen free of charge. If it turns out there’s nothing wrong, there's no charge. If treatment or medicine is required, prices are published on the website, so clients can see exactly what everything costs.
Founder Owen Monie says: “We are here to provide a comprehensive vet service for people who earn a real, living wage. We want to deliver the best access to good vet care and to remove the barriers that stop people getting care for their animals – that’s why we provide free consultations. This means pet owners can get professional advice without worrying about having to pay a consultation fee. If no treatment is needed – there’s no fee. It’s as simple as that.”
Owen says that large corporations argue they can bring better management, efficiency and innovation to the sector, and claim that costs have gone up in part due to advances in animal medicine and clients’ expectations.
"That may well be true, but big isn’t always better. In addition to its legal status as a CIC, Animal Trust lives by a set of core values (straightforward, accessible, sustainable and fair) that are becoming increasingly meaningful to customers and clients as an alternative to companies who appear to be only interested in the bottom line. There isn’t an NHS equivalent for animals – so is becoming a CIC the model that all vet practices should be looking to adopt?"
The ‘Advances in Diabetes’ module, taking place at BSAVA Congress 2024 in Manchester Central, will offer delegates the chance to hear first-hand from the clinical researchers and specialists who have used these drugs, such as Dr Ellen Behrend, Prof Ian Ramsey, Prof Stijn Niessen, and Dr Anna Lena Kramer.
Stijn said: “Although not suited as a sole therapeutic for dogs, the current data suggests that a majority of diabetic cats could be treated with once daily oral formulations of these drugs.
“Some of the past barriers to successful long term diabetic treatment included the owner having to inject insulin twice daily and having to watch for hypoglycaemia.
"These lifelong impacts on the owner’s lifestyle are now being taken away.”
Delegates will also be able to learn about advances in the monitoring of canine diabetes, such as the use of Freestyle Libre monitors and haemoglobin A1c, as well as a review of recent developments and management practices for ‘complicated’ cases.
Stijn added: “Gone are the days that we saw diabetes mellitus as a disease; instead, it is the consequence of one or many diseases.
“As such we now ought to approach diabetic cases with a much more open mind and being willing to try and determine the exact aetiology of the diabetes mellitus, doing so can pay off and prevent a diabetic case from becoming a complicated case.”
Ellen added: “Although diabetic ketoacidosis is no more common with the use of SGLT2-inhibitors, it is more likely to be euglycemic with a blood glucose <13.9 mmol/L.
"The recognition of euglycemic ketoacidosis and the correct approach of treatment is crucial.”
Stjn concluded: “Each patient is an individual and therefore diagnosis, treatment and monitoring practices should be adapted to the individual pet-owner combination.
Vets must adjust their approaches significantly when using these drugs, the ‘Advances in Diabetes’ module will provide an in-depth look at these adjustments.”
Delegates will also be able to get their hands on the brand new fifth edition of the BSAVA Manual of Canine and Feline Endocrinology, which includes a chapter on feline diabetes mellitus that discusses various treatments including the use of SGLT2-inhibitors.
Jacquie Rand, author of the chapter said: “SGLT2-Inhibitors will be a game-changer for diabetic cats and their owners. However, it is important that cats are diagnosed earlier in the disease process while some insulin secretory capacity is present, for these to be used as the sole drug therapy.”
The BSAVA Manual of Canine and Feline Endocrinology will be available to purchase on the BSAVA Publications Stand in the Exhibition Hall. ‘Advances in Diabetes’ will take place on Thursday 21st March in the Exchange Hall.
Registration for BSAVA members starts at £115 +VAT for a one-day event pass.
https://www.bsavacongress.com.
Illustration: What a presentation about SGLT2-Inhibitors might look like (this has been photoshopped)
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
The first opinion Linnaeus Group practice, which also holds RCVS hospital status, is run by a team of nine vets, 14 nurses, nine receptionists and four animal care assistants.
It was given an outstanding rating for client service, inpatient service, patient consultation service and team and professional responsibility.
Maureen Geraghty Sathi, Practice Manager at Maven said: "We’re always asking ourselves how could we do this better? Everyone has to be on board or it would not work."
The practice had a focus team look at awards and the improvements it would need to make to achieve the required standards. Amongst the various things that were highlighted as exceptional were:
A genuinely separate cat waiting area and cat consult room.
An extensive pain monitoring system with pain scoring for all patients in hospital and an outpatient system which enables clients to monitor and chart their pets pain levels at home and review them with their vet.
Daily clinical rounds which involve the entire clinical team as well as management and a member of the customer care team. Aside from discussing clinical cases for the day this platform also enables daily review of any significant events or morbidity and mortality cases to be highlighted and time allocated for review.
A system whereby vets at the practice email clients in advance of any surgical procedure with information on the procedure itself as well as any potential risks associated with the procedure allowing time for further discussion with the client as needed
Consistent use of surgical and GA checklists to maximise patient safety.
In the final report, the RCVS practice standards assessor wrote: "The structures and management in place were of the very highest order. I was really impressed by the commitment of this practice to provide the very highest standards of clinical care to its clients."
Maureen said: "I am massively proud of the team, to see the pride in how they work. It is lovely to be told that you are working to an extremely high level and genuinely reflects the standards of the team day by day."
The British Veterinary Association has responded to the announcement of a recruitment drive by the newly-formed British Veterinary Union (BVU) and Unite.
Harvey Locke, President of the BVA, said: "Those working in veterinary practice have always been able to join Unite or any other trade union, and it is unclear whether vets are actually being offered anything new in this recruitment campaign.
"The BVA provides the majority of services traditionally offered by a union and we are constantly working to improve our services to support the veterinary team. In the last two years we have developed mediation and legal representation services to help members through difficult issues in the workplace. The BVA's 24/7 legal helpline remains one of our most valued services with up to 600 calls year on employment and personal issues. We also produce and update a wide range of advice and guidance on all aspects of veterinary employment.
"All of our services continue to be developed using the expertise and experiences of our members.
"In addition to these support services the BVA package incorporates much more. The BVA is a key stakeholder of the RCVS, Defra, Welsh, Scottish and Northern Ireland administrations, the VMD and other bodies, representing members on issues as diverse as pet travel, bovine TB and medicines regulations. This is not a role Unite could play for our profession."
The RSPB has reported the results of two studies which revealed that a greater diversity of birds of prey, including some eagles, are killed eating carrion contaminated with diclofenac.
The RSPB says that these findings strengthen the case of banning the use of veterinary diclofenac in livestock across Europe, including Spain and Italy where the drug has already been approved.
In the first paper1, published in the journal Bird Conservation International, scientists present results of tests carried out on two steppe eagles found dead at a cattle carcass dump in Rajasthan, India. Both birds had diclofenac residue in their tissues and exhibited the same clinical signs of kidney failure as seen in Gyps vultures experimentally given diclofenac.
Steppe eagles are closely related to the golden eagles found in the UK, the vulnerable Spanish imperial eagle and other globally vulnerable or declining Eurasian eagles. Scientists now fear that all species in this genus, known as Aquila, are susceptible to diclofenac. With fourteen species of Aquila eagle distributed across Asia, Africa, Australia, Europe and North America, this means that diclofenac poisoning should now be considered largely a global problem.
Dr Toby Galligan, RSPB conservation scientist and one of the authors of the paper, said: "We have known for some time that diclofenac is toxic to Gyps vultures, including the Eurasian griffon vulture, but we now know it is toxic to an Aquila eagle too. This suggests that the drug is fatal to a greater number of birds of prey in Asia, Europe and around the world. We had suspected as much from observed declines in non-Gyps vultures in Asia, but this study confirms our worst fears."
In another paper2, published in Bird Conservation International, Dr Galligan led an examination of recent population trends in Egyptian and red-headed vultures in India. That study shows population declines of similar timing and scale as the declines observed in Gyps vultures, providing indirect evidence that these species have been impacted by diclofenac as well.
After years of campaigning by conservationists, the governments of Bangladesh, India, Nepal, and Pakistan banned veterinary formulations of diclofenac between 2006 and 2010. Recently, experts have recorded a slowing of Gyps vulture declines as a result of the bans. However, formulations of diclofenac intended for use in humans are still widely available and illegally used to treat livestock, the carcasses of which are the main food source for vultures in South Asia. It was announced in March that veterinary diclofenac had been authorised for manufacture and use in Italy and Spain and had been distributed to other European countries. Since then, a coalition of organisations including the Vulture Conservation Foundation, the RSPB and BirdLife International have been campaigning for this decision to be reversed.
Dr Galligan continued: "In light of recent developments in Europe, our findings take on an even more worrying meaning. All of Europe's charismatic Aquila eagles, like the Spanish imperial eagle and, closer to home, the golden eagle, are opportunistic scavengers and therefore could be at risk of diclofenac poisoning. As we have seen in South Asia, wherever free-ranging livestock are treated with diclofenac, population declines in vultures and eagles can occur. The European Commission needs to recognise this problem and impose a continent-wide ban on veterinary diclofenac before it can impact on our birds."
Last week, the Veterinary Medicines Directorate (VMD) announced measures against the drug.
In a statement the VMD said: "The UK's Veterinary Medicines Directorate is taking the issue of diclofenac's risks to vulture populations seriously. As a precautionary measure the VMD will not approve any requests from vets to import products containing diclofenac. Furthermore, the VMD has agreed not to issue any export certificates which name diclofenac-containing products in the list of products to be exported."
Sacha Cleminson, Head of International Biodiversity Policy at the RSPB, said: "The announcement from the Veterinary Medicines Directorate is a welcome signal to Europe that the UK is taking the issue seriously. This new evidence underlines the need for a ban across Europe, and ultimately beyond."
References
Have population declines in Egyptian Vulture and Red-headed Vulture in India slowed since the 2006 ban on veterinary diclofenac? Toby H. Galligan et al. Bird Conservation International Online. 1st April 2014.
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Reference
There are 10 candidates standing in this year’s elections, including four existing Council members eligible for re-election and six candidates not currently on Council. They are:
Mr David Catlow MRCVS
Mr John C Davies MRCVS
Dr Mandisa Greene MRCVS
Miss Karlien Heyrman MRCVS
Professor John Innes FRCVS
Dr Thomas Lonsdale MRCVS
Dr Susan Paterson FRCVS
Mr Matthew Plumtree MRCVS
Mr Iain Richards MRCVS
Colonel Neil Smith FRCVS
Ballot papers and candidates' details have been posted to all veterinary surgeons eligible to vote and an email containing a link to a secure voting site unique to each member of the electorate has also been sent by Electoral Reform Services which runs the election on behalf of the College.
All votes must be cast, either online or by post, by 5pm on Friday 27 April 2018.
This year the College invited all election candidates to produce a video in which they answered up to two questions submitted directly to the RCVS from members of the electorate. All videos have been published on the RCVS website (www.rcvs.org.uk/vetvote18) and YouTube channel (www.youtube.com/rcvsvideos).
Key question themes this year included recruitment and retention, the College’s concerns investigation process and veterinary education. The list of accepted questions has also been published on the RCVS website.
The biographies and statements for each candidate in the RCVS Council election can be found at www.rcvs.org.uk/vetvote18.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "Last year we had a record number and proportion of the electorate vote in an RCVS Council election and we would once again stress the importance of voting to ensure that you have a say in the future direction of travel for the College and its policies."
Those who are eligible to vote but have not received either an email or ballot paper should contact Luke Bishop, RCVS Senior Communications Officer, on l.bishop@rcvs.org.uk.
The two companies have agreed to jointly discover and develop species-specific therapeutic monoclonal antibodies for companion animals, a class of drug which they say is neglected in veterinary medicine but offers a variety of future therapeutic options for diseases that cannot be adequately treated today.
adivo will select species-specific antibodies using its proprietary fully canine phage display library. Bayer Animal Health will provide targets involved in severe animal diseases.
Dr. Douglas Hutchens, Bayer Animal Health’s Head of Drug Discovery, External Innovation & Chief Veterinary Officer, said: "Today’s agreement is another example of how we realize our innovation strategy
"By combining the know-how from creative start-up companies like adivo with opportunities derived from Bayer’s research, we broaden our space of therapeutic medicine options and complement our portfolio.
"We are constantly looking for innovative technologies that enable us to generate novel treatment options for the companion animal sector. Now, we will focus on evolving the options presented by adivo from research and development to market maturity."
Dr. Kathrin Ladetzki-Baehs, Managing Director of adivo said: "At adivo, we truly believe that pets have a positive impact on our society. By developing novel medicines for companion animals, we want to make a difference for veterinarians and pet-parents. Today, we are more than pleased and excited to have gained such a committed and experienced collaboration partner, to jointly develop new treatment options."
The partnership includes a minimum donation of £10,000 which the company hopes to bolster with additional volunteering and fundraising support.
Gerard Ensink, Head of Animal Health UK and Ireland at Boehringer Ingelheim said: “We are truly delighted to be supporting StreetVet.
“There is already so much passion for the charity within our company.
"Even before we announced this charity partnership, several of our colleagues have been volunteers with StreetVet in a personal capacity.
"We look forward to supporting StreetVet and believe that together we can make a real difference to individuals and their pets who are experiencing homelessness.”
https://www.streetvet.co.uk
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
CVS has announced its acquisition of the Dovecote Veterinary Hospital, a general and referral practice based in Castle Donington near Derby.
The Dovecote offers a range of referral services including digital X-ray, MRI and CT scanning capability. Its directors, Andrew Robinson, a European RCVS Recognised Specialist in Small Animal Surgery, and Alison Robinson have been appointed joint Clinical Directors.
Dovecote joins ChesterGates Veterinary Specialists in Chester, Norfolk-based Grove Referrals and St David's Veterinary Group in Devon in CVS' referral practice portfolio. The Group also has a new veterinary hospital - Lumbry Park Veterinary Specialists - under construction at Alton, Hampshire; opening in October 2015.
In addition to the Dovecote, CVS has announced the acquisition of further first opinion practices based in Yorkshire and Wales. They are:
Simon Innes, Chief Executive of CVS, said: "These latest acquisitions show continued progress towards our goal of building a strong presence throughout all sectors of veterinary practice. It is a particularly exciting time for our referral team and we are delighted to welcome the team from Dovecote, as well as the other new practices which have joined us recently."
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."
The study, which was carried out by researchers from the School of Veterinary Medicine and Sciences at the University of Nottingham, is one of the first to look at colostrum hygiene in Great Britain. The researchers analysed data from 328 colostrum samples from 56 British dairy farms.
Samples collected from collection and feeding equipment had higher levels of bacteria than those collected directly from the cows’ teat, suggesting that whilst colostrum from the cow is relatively low in bacterial levels, improperly cleaned equipment can be a major source of bacterial contamination. Over one third of samples collected from collection or feeding equipment were over the threshold for high bacterial levels and represented a significant risk to the health of calves.
Dr Robert Hyde (pictured right), one of the researchers on the study, said: “By analysing colostrum collection protocols on the farms, we were able to identify a small number of management practices likely to have a substantial impact on colostrum hygiene for the majority of farms.
"For example, the use of scalding hot water to clean collection and feeding equipment could reduce bacteria levels by over 90% compared with using cold water only. Less than half of farms used scalding hot water to clean colostrum collection and feeding equipment, suggesting there are a large number of farms that could make this simple change.”
The main recommendations from the research are that colostrum hygiene protocols should include the cleaning of colostrum collection and feeding equipment after every use with hot water as opposed to cold water, and hypochlorite or peracetic acid as opposed to water or parlour wash.
Cows' teats should be prepared with a pre-milking teat disinfectant and wiped with a clean, dry paper towel prior to colostrum collection, and colostrum should be pasteurised where possible.
The AHDB guide to colostrum hygiene can be found here: https://www.youtube.com/watch?v=FziQX0B9yb4
Robert added: “This study provides a first look at bacteria levels in Great Britain, and the results suggest there are a few simple changes to collection and cleaning protocols that could have a significant impact on colostrum hygiene levels on British dairy farms. By making these simple changes there is likely to be significant improvement in colostrum hygiene, which is essential in minimising the risk of disease and ensuring the optimum health and welfare of calves on dairy farms.”
The full study is open access and can be found here: https://www.frontiersin.org/articles/10.3389/fvets.2020.601227/full
The University of Nottingham herd health toolkit contains a “Colostrum bacteriology” section, where vets and farmers can use the results from this study to see what management changes might have the largest impact on colostrum hygiene, can be found here: https://herdhealth.shinyapps.io/toolkit/
Norbrook Laboratories Ltd has launched a second generation Eprinomectin Pour On solution with zero milk withhold and a 10 day meat withdrawal period. Eprizero, for beef and dairy cattle, is indicated for the treatment and prevention of a range of economically damaging gutworm and lungworm infections and external parasites in a pour on application. It offers zero milk withhold and an improved meat withdrawal period of 10 days. Andrew Hillan MVB MRCVS, Director of Veterinary Science, Norbrook Laboratories Ltd., said: "Norbrook has launched Eprizero to offer vets and farmers a more versatile alternative in the treatment of economically damaging worms and external parasites. The active ingredient in Eprizero, Eprinomectin, is both potent and fast-acting and is supported by independent studies which show increased milk yield, improved fertility and increased dry matter intake following treatment. With a zero milk and 10 day meat withdrawal and waterproof properties, Eprizero offers real versatility to vets and farmers in terms of when and where they treat. It is this versatility that we believe will make Eprizero the gold standard in anthelmintic treatment for prolonged infestations of gut worm and lung worm in both dairy and beef cattle." Eprizero is available in four sizes - 250ml, 1L, 2.5L and 5L - with a free 75ml gun supplied with the two larger pack sizes. It is administered using a 75ml dispensing gun to enable accurate application. Eprizero is registered for use in the UK and Ireland and is available to order from your local Norbrook Sales Representative.
The procedure is called radiocatheter ablation. It's used regularly in humans but there are only three or four centres in the world that perform the procedure routinely on veterinary patients and Pedro is the only veterinary cardiologist currently performing it in the UK.
DVS says the procedure can achieve a cure for previously incurable conditions, without the need for further medical treatment with drugs that have potential side effects. It involves inserting catheters into veins in the legs and neck and then guiding them into the heart. Electrical signals can be recorded to show where the abnormal heartbeats are generated ('mapping'). Once this is achieved, heat is used to destroy the tiny abnormal area of the heart muscle and make the arrhythmia disappear ('zapping'). Recovery is straightforward and the condition can be completely cured.
Jake, a three-year-old Labrador Retriever, is one of seven dogs that have been cured by Pedro and the team so far.
Jake suffered from life-threatening cardiac arrhythmia, causing his heart to beat at over 250 beats per minute for prolonged periods. Such an elevated heart rate cannot be sustained for long and may result in damage to the heart muscle. Jake had been diagnosed a number of months ago and initially responded to anti-arrhythmic drugs. However, the drugs stopped working and his heart was sustaining damage and showing early signs of weakness. The radiocatheter ablation cured his condition completely and he can now lead a normal healthy life.
Jake’s owner, Mrs Chapman from Staffordshire, said: "We would like to thank everyone at Davies Veterinary Specialists for looking after Jake during his three day stay in April 2016. Special thanks to Pedro Oliveira and his cardiac team for operating on Jake and correcting his heart condition. Jake is no longer taking any medication and has made a full recovery. We now have a much happier, more energetic Labrador, ready for walks and play at every opportunity. Jake seems to have a smile on his face everyday now and is enjoying life to the full."
Pedro said: "We have treated seven patients in the past year, all with success and without complications. Unfortunately a significant proportion of candidates for these procedures are in desperate situations with failing hearts and after all drugs have failed before they reach us. Hopefully, with greater awareness of the availability of this procedure, we can treat more patients before it gets to be that bad."
Clive Elwood, Managing Director of Davies Veterinary Specialists said: "This is a great example of how our team of specialists can deliver ground-breaking and innovative care, which makes a real difference for both patients and their loving owners."
Pedro is happy to discuss the suitability of cases with vets managing dogs with arrhythmias. Contact him at cardiology@vetspecialists.co.uk or find out more at www.vetspecialists.co.uk
The toolkit includes a 15-minute CPD webinar: ‘How to best use ProZinc to successfully manage diabetes in cats and dogs’, hosted by Dr Jamie Adams BVSc PhD MRCVS, Senior Brand Technical Advisor at Boehringer Ingelheim.
Vets who watch the webinar can enter a competition for a coffee machine for their veterinary practice by answering three questions at the end.
The toolkit also has a diabetes management reference guide covering how to make a confident diagnosis and start treatment with ProZinc, how best to monitor and reassess the patient and how to adjust the dose for optimal control.
There are also glucose curve charts, pet owner guides, home care journals and a link to the ProZinc pet owner website, www.prozinc.co.uk, which contains information to help owners feel confident in managing their pet’s diabetes.
The webinar and toolkit are available from: www.boehringer-academy.co.uk.
Axiom Laboratories has launched MiPetAllergy, a pet allergy test which the company says is not affected by medication and which requires no withdrawal period prior to testing.
Axiom developed the MiPetAllergy in partnership with ALK, which makes Artuvetrin. With its food elimination diet selector tool, developed in association with Royal Canin, it tests against as many as 80 environmental allergens and foods.
Dan Sherry, General Manager at Axiom, said: "Allergies are increasing among companion animals and identifying accurately which allergen is causing the problem in a particular pet can be one of the toughest challenges veterinary staff face in practice.
"MiPetAllergy represents two and half years of research so we are delighted to announce its arrival. Axiom is confident that there will be complete concordance between the screen and panel results that they are offering a money back guarantee if they are discordant. We hope it will help practices dealing with allergy patients to identify and treat for the specific allergens causing their symptoms."
Martyn Carpenter, Director of Axiom, added: "The introduction of the MiPetAllergy testing is timely as it coincides with the change in Axiom’s supplier of immunotherapy. During November and December 2014 the Veterinary Medicines Directorate (VMD) started rejecting applications for STC’s and advising that European Licensed immunotherapy products should now be used in the UK as part of the Cascade. Both our new allergy test and new vaccines are manufactured by the same company."
Having experienced the profession both as a clinician and as a director, Clive says he wanted to develop and integrate his skills to support fellow professionals. So, during lockdown, he embarked on a Master’s in Executive Coaching from Ashridge Hult Business School.
Clive said: "Studying for the Master’s was intellectually and emotionally tough. The emphasis was on psychology and relationships, working to the highest standards of ethical coaching practice. It has not only developed my coaching skills but also afforded me the opportunity to scrutinise the drivers and motivations behind my career choices and integrate them into a wider appreciation of life and my ‘self’. I am incredibly proud of this achievement and conscious of the privilege afforded me."
Clive's service typically involves six ninety-minute sessions during which he'll help you develop skills, behaviours and ways of behaving that will make you a better leader, particularly if you come from a clinical background where you'd be used to using very different skillset.
Clive, who is also a European Mentoring and Coaching Council Senior Practitioner, added: "In my practice as a coach, I am grateful for the opportunity to support others, whatever their life experiences, as they negotiate the challenges of being themselves, in the workplace, serving their communities.”
For more information, visit: www.trelliscoaching.co.uk
The Soil Association is calling on the Government to issue guidelines that will limit the veterinary use of the most modern penicillin-type antibiotics, to prevent the spread of a serious new superbug.Recently released minutes of a Government committee reveal that Ministers have been briefed about the emergence on a British dairy farm of a mutant strain of antibiotic-resistant E. coli which causes life-threatening cases of food poisoning, including hemorrhagic colitis and haemolytic uraemic syndrome.
The bug, known as E. coli O26 is a vera-toxin producing E. coli (VTEC), similar to the infamous E. coli O157. According to the Soil Association, what makes the discovery of this variant so significant is that this is the first time in the UK, and only the third time in the world, that VTEC E. coli has been found with an enhanced type of antibiotic resistance known as extended-spectrum beta-lactamase (ESBL), which makes it resistant to almost all antibiotics. ESBL resistance has previously been found on 57 UK farms, but until now only in strains of E. coli that cause urinary tract infections and blood poisoning.Although antibiotics are not recommended for the treatment of VTEC E. coli, scientists warn that the emergence of resistance is undesirable because these resistant bacteria are encouraged every time certain antibiotics are used, resulting in increased spread and greater risk of contaminated food products. On non-organic dairy farms, cows are routinely given antibiotics at the end of their lactation to prevent mastitis. In addition, milk from cows given antibiotics for treatment, or prevention, is often fed to calves when it contains residues and cannot be sold. However, because ESBL E. coliO26 is resistant to all the antibiotics used in ‘dry cow therapy' and many of those used for treatment, the high use of antibiotics on dairy farms will promote the rapid spread of these dangerous bacteria.Soil Association Policy Adviser, Richard Young said: "This is one of the most worrying developments in the continuing rise of ESBL E. coli. Today is the first European Antibiotics Awareness Day, but there is a distinct lack of awareness that the continuing high use of antibiotics in farming is contributing to the increase in antibiotic-resistant infections in humans."The Government often calls on doctors to prescribe antibiotics less often. But similar advice needs to be given to veterinary surgeons and farmers. Half of all antibiotics are given to animals, and there is mounting evidence that antibiotic-resistant bacteria in farm animals pass to humans. If we want antibiotics to save lives in the future as they have done in the past then the Government must provide specific recommendations based on scientific advice, and vets need to pull together with doctors to limit the use of problematic drugs."